Evidence map›Paper›PMID 41281176›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Biodistribution and Semiquantitative Analysis of

Sachin Tayal, Ritwik Sinha, Varun Shukla, Manikandan Marappagounder Venkatachalam, Arvind Suresh, Jay Prakash Kumar, Manojkumar Ramsoorat Chauhan, Yash Jain, Uddeshya Narayan Jha, Simran Kalra

Abstract read
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sachin TayalDepartment of Nuclear Medicine and Molecular Imaging, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, Uttar Pradesh, India.
Ritwik SinhaDepartment of Nuclear Medicine and Molecular Imaging, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, Uttar Pradesh, India.
Varun ShuklaDepartment of Nuclear Medicine, Homi Bhabha Cancer Hospital and Research Centre, Tata Medical Centre, New Chandigarh, Punjab, India.
Manikandan Marappagounder VenkatachalamDepartment of Nuclear Medicine and Molecular Imaging, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, Uttar Pradesh, India.
Arvind SureshDepartment of Nuclear Medicine and Molecular Imaging, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, Uttar Pradesh, India.
Jay Prakash KumarDepartment of Nuclear Medicine and Molecular Imaging, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, Uttar Pradesh, India.
Manojkumar Ramsoorat ChauhanDepartment of Nuclear Medicine and Molecular Imaging, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, Uttar Pradesh, India.
Yash JainDepartment of Nuclear Medicine and Molecular Imaging, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, Uttar Pradesh, India.
Uddeshya Narayan JhaDepartment of Nuclear Medicine and Molecular Imaging, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, Uttar Pradesh, India.
Simran KalraDepartment of Nuclear Medicine, Homi Bhabha Cancer Hospital and Research Centre, Tata Medical Centre, New Chandigarh, Punjab, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: To emphasize the feasibility of imaging prostate cancer patients under SPECT/CT with Introduction: In context to prostate specific membrane antigen's (PSMA) overexpression in prostate cancer cells there has been a gradual increase in imaging prostate cancer, currently the second leading cause of cancer deaths in males and the sixth cause of cancer death worldwide, with the help of radiolabeled PSMA small molecule inhibitors over the past few years. Of the two modalities under Nuclear Medicine facility (positron emission tomography/CT [PET/CT] and single photon emission CT [SPECT/CT]), though PET/CT has high sensitivity for tumor sites, even at low PSA level less however, the availability of 18F based radiotracer for PET imaging necessitates the dependency on a cyclotron in the near vicinity for production or regular supply. Another option of Germanium 68/ Gallium 68 generator ( Material and Method: A retrospective analysis was conducted on 39 patients who had undergone Results: The biodistribution of Conclusion: The biodistribution of

Indexed as

99mTc-HYNIC-prostate-specific membrane antigen-11biodistributionprostate cancer

Identifiers

PMID41281176
PMCPMC12633813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.